Shares of UnitedHealth Group Incorporated (NYSE:UNH) have earned a consensus rating of “Buy” from the twenty-six analysts that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and twenty-four have issued a buy recommendation on the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $201.71.

A number of equities analysts recently commented on UNH shares. Sanford C. Bernstein reissued an “outperform” rating and issued a $190.00 target price on shares of UnitedHealth Group in a report on Monday, July 10th. Cantor Fitzgerald reiterated a “buy” rating and issued a $205.00 price objective on shares of UnitedHealth Group in a report on Friday, July 7th. Credit Suisse Group reiterated an “outperform” rating and issued a $200.00 price objective (up previously from $195.00) on shares of UnitedHealth Group in a report on Thursday, July 13th. Citigroup Inc. raised their target price on UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a research report on Wednesday, July 19th. Finally, Royal Bank Of Canada reissued a “buy” rating and set a $212.00 target price on shares of UnitedHealth Group in a research report on Thursday, July 20th.

COPYRIGHT VIOLATION WARNING: This story was reported by Watch List News and is the property of of Watch List News. If you are viewing this story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The legal version of this story can be accessed at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-receives-201-71-consensus-target-price-from-analysts/1606008.html.

In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the sale, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the sale, the director now directly owns 76,058 shares in the company, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders have sold 76,174 shares of company stock valued at $14,981,909 over the last three months. 0.89% of the stock is currently owned by corporate insiders.

Several hedge funds have recently modified their holdings of UNH. Honeywell International Inc. purchased a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $35,262,000. Suntrust Banks Inc. raised its position in UnitedHealth Group by 8.5% in the first quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock worth $42,774,000 after acquiring an additional 20,541 shares in the last quarter. Factory Mutual Insurance Co. raised its position in UnitedHealth Group by 20.9% in the second quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock worth $77,245,000 after acquiring an additional 72,000 shares in the last quarter. Shell Asset Management Co. raised its position in UnitedHealth Group by 0.8% in the second quarter. Shell Asset Management Co. now owns 157,241 shares of the healthcare conglomerate’s stock worth $29,156,000 after acquiring an additional 1,254 shares in the last quarter. Finally, Moody Lynn & Lieberson LLC raised its position in UnitedHealth Group by 569.9% in the second quarter. Moody Lynn & Lieberson LLC now owns 8,937 shares of the healthcare conglomerate’s stock worth $1,657,000 after acquiring an additional 7,603 shares in the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Shares of UnitedHealth Group (NYSE:UNH) traded up 0.60% during trading on Friday, reaching $198.63. 2,533,800 shares of the company were exchanged. The stock has a market capitalization of $192.05 billion, a P/E ratio of 23.86 and a beta of 0.63. The firm has a 50-day moving average price of $195.77 and a 200-day moving average price of $182.90. UnitedHealth Group has a 1-year low of $133.03 and a 1-year high of $200.76.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. During the same quarter in the previous year, the firm posted $1.96 earnings per share. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group will post $9.87 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were issued a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.51%. The ex-dividend date of this dividend was Thursday, September 7th. UnitedHealth Group’s payout ratio is 35.13%.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.